earnings

Abbott misses Wall Street expectations on Q4 sales
Mass Device
Wed, 01/23/19 - 10:37 am
Abbott Labs
devices
earnings
J&J CEO: We Know We Still Have More Work to Do [in Devices]
Medical Devices and Diagnostics Industry
Wed, 01/23/19 - 09:37 am
JNJ
earnings
devices
Alex Gorsky
Discounting hit J&J's Xarelto hard. Can a new launch turn things around?
Fierce Pharma
Tue, 01/22/19 - 11:56 pm
JNJ
earnings
Xarelto
Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year
CNBC
Tue, 01/22/19 - 12:02 pm
JNJ
earnings
Johnson & Johnson Is Trying to Recover From Plunge
Investopedia
Fri, 01/18/19 - 10:13 am
JNJ
earnings
Becton Dickinson’s fiscal Q1 prelims beat The Street
Mass Device
Thu, 01/17/19 - 10:03 am
Becton Dickinson
earnings
devices
Intuitive Surgical Earnings: Mark Your Calendar
Motley Fool
Thu, 12/27/18 - 10:13 pm
earnings
devices
Intuitive Surgical
Medtronic’s Q2 results top estimates despite profit slide
Mass Device
Tue, 11/20/18 - 09:51 am
Medtronic
earnings
devices
Momenta Moves On
Motley Fool
Fri, 11/16/18 - 07:58 pm
Momenta
earnings
biosimilars
M281
M254
Flat quarter for Bayer, shares drop 3%
GoinPharma
Fri, 11/16/18 - 10:01 am
Bayer
earnings
ImmunoGen Waits to Leap "Forward"
Motley Fool
Sat, 11/10/18 - 12:46 pm
Immunogen
earnings
Waiting for bluebird bio to Sing at ASH
Motley Fool
Sat, 11/10/18 - 12:05 pm
Bluebird Bio
earnings
ASH
CAR-T
Dentsply announces workforce reductions & restructuring plan, posts Q3 miss
Mass Device
Thu, 11/8/18 - 08:50 pm
Dentsply Sirona
layoffs
dental health
earnings
AstraZeneca Reports First Quarter of Sustainable Product Sales Growth Since 2014
BioSpace
Thu, 11/8/18 - 12:24 pm
AstraZeneca
earnings
Here's Why Myriad Genetics Dropped as Much as 10.8% Today
Motley Fool
Wed, 11/7/18 - 07:07 pm
Myriad Genetics
earnings
Despite Trulicity success, Lilly can't escape diabetes concerns
Biopharma Dive
Wed, 11/7/18 - 12:00 am
Eli Lilly
diabetes
earnings
Trulicity
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Motley Fool
Tue, 11/6/18 - 11:33 am
Mylan
earnings
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Tue, 11/6/18 - 09:34 am
Exelixis
earnings
kidney cancer
Cabometyx
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Mass Device
Tue, 11/6/18 - 09:32 am
earnings
Becton Dickinson
devices
Excellent quarter from AbbVie, but market still skeptic about pipeline
GoinPharma
Sun, 11/4/18 - 02:50 pm
AbbVie
earnings
Imbruvica

Pages